Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting

被引:0
|
作者
Michael Scott Kook
Susan Simonyi
Yong Ho Sohn
Chan Yun Kim
Ki Ho Park
机构
[1] Asan Medical Centre,Department of Ophthalmology
[2] Allergan Singapore Pte,Department of Ophthalmology
[3] Ltd.,Department of Ophthalmology
[4] Mapletree Business City,undefined
[5] Kim’s Eye Hospital,undefined
[6] Yonsei University,undefined
[7] College of Medicine,undefined
[8] Seoul National University Hospital,undefined
来源
Japanese Journal of Ophthalmology | 2015年 / 59卷
关键词
Bimatoprost; Glaucoma; Hyperemia; Ocular hypertension; Prostamide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:325 / 334
页数:9
相关论文
共 50 条
  • [21] Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension
    Ling Zhihong
    Zhang Mingchang
    Hu Yizhen
    Yin Zhengqin
    Xing Yiqiao
    Fang Aiwu
    Ye Jian
    Chen Xiaoming
    Liu Dachuan
    Wang Yusheng
    Sun Wei
    Dong Yangceng
    Sun Xinghuai
    中华医学杂志(英文版), 2014, 127 (05) : 905 - 910
  • [22] Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Felipe A. Medeiros
    Arsham Sheybani
    Manjool M. Shah
    Marcos Rivas
    Zhanying Bai
    Erica Werts
    Iqbal I. K. Ahmed
    E. Randy Craven
    Ophthalmology and Therapy, 2022, 11 : 1517 - 1537
  • [23] Clinical characteristics of Latinos with open-angle glaucoma and ocular hypertension
    Pena, FY
    Lai, MY
    Francis, BA
    Nguyen, BB
    Deneen, J
    Wilson, MR
    Azen, SP
    Varma, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U453 - U453
  • [24] OCULAR HYPERTENSION OR EARLY GLAUCOMA - OCULAR HYPERTENSION VS OPEN-ANGLE GLAUCOMA
    CHANDLER, PA
    GRANT, WM
    ARCHIVES OF OPHTHALMOLOGY, 1977, 95 (04) : 585 - 586
  • [26] Comparative effectiveness of bimatoprost 0.03% preservative free for the treatment of open-angle glaucoma and ocular hypertension
    Brereton, N.
    Stradwick, S.
    Harvey, B.
    Shergill, C.
    Patel, V.
    Wong, W.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [27] A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension
    Day, DG
    Schacknow, PN
    Sharpe, ED
    Ellyn, JC
    Kulze, JC
    Threlkeld, AB
    Jones, ED
    Brown, RH
    Jenkins, JN
    Stewart, WC
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 20 (05) : 383 - 392
  • [28] Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
    Brief, Gerrett
    Lammich, Tobias
    Nagel, Edgar
    Pfennigsdorf, Sabine
    Spraul, Christoph W.
    Ho, Selwyn
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 1125 - 1129
  • [29] Effectiveness and Safety of Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment
    Cronemberger, Sebastiao
    Franca, Jucara R.
    Faria Araujo, Alan Cezar
    da Cunha, Francine Rubiao
    Gomes Faraco, Andre Augusto
    Ferreira, Anderson
    Foureaux, Giselle
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [30] Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
    Myers, Jonathan S.
    Vold, Steven
    Zaman, Fiaz
    Williams, Julia M.
    Hollander, David A.
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 643 - 652